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SUMMARY
A significant number of Brazilian gestational-age women are still not tested for HIV, representing a high risk of transmission to 
their newborns. The current study sought to identify the number of pregnant women with no previous testing or undocumented for 
HIV referred to the Gynecology and Obstetrics Department of a Regional Teaching Hospital and included diagnosis of HIV infection 
determined by a rapid test and perinatal transmission in pregnancy. Medical records of all pregnant women admitted to hospital from 
January 2001 to December 2005 were reviewed. Pregnant women without HIV results were submitted to a rapid HIV test. Those who 
tested positive were further tested by ELISA and confirmed by indirect immunofluorescence assay (IIA) or Western blot (WB). The 
viral load from babies born to HIV-infected mothers was assessed by bDNA. Of the 16,424 pregnant women analyzed (6.6%), 1,089 
were undocumented for HIV. Eleven women were positive in rapid testing and 10 were confirmed by ELISA, IIA or WB, with 0.9% 
seropositivity. Mother/infant pairs received zidovudine monotherapy prophylaxis and infant viral load was lower than 50 copies/mL. A 
higher number of pregnant women previously tested for HIV during antenatal care was verified, compared to that obtained nationwide.
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INTRODUCTION
The AIDS epidemic affects approximately 33 million people 
worldwide. In Latin America, the infection remains generally stable 
and almost half of the people living with HIV are women. In the last 
decade there has been an increase in the incidence of HIV/AIDS among 
young women and a large proportion of infections can be attributed to 
the behavior of their male sexual partners1,16,32. This factor is even more 
evident where the heterosexual relationship is the dominant manner of 
HIV transmission25,32. Married women form the epidemiological group 
with the greatest increase in HIV-infection, due to the large number 
of women who are not aware of their husbands’ HIV status32. In the 
state of São Paulo, the female/male ratio of new HIV infections shifted 
progressively from 1:27 in the 1980’s to 1:3 by the mid 1990’s, to 1:2 
of new cases during the last five years. In some Brazilian regions, the 
infection ratio between the sexes is already 1:130. 
Since most of the infected women are of reproductive age, another 
branch of the expanding HIV epidemic is perinatal virus transmission. 
Approximately 5-10% of all cases of HIV are children. The majority 
acquire the infection through mother-to-child transmission (MTCT) inside 
the uterus, during labor or delivery, or by breastfeeding. Most of these cases 
live in sub-Saharan Africa16,32 and the global epidemiology of pediatric HIV 
infection reflects the epidemiology of HIV among women32. 
Worldwide, a significant number of pregnant women are not tested 
for HIV before labor and delivery, thus they represent a high-risk 
population10. In Brazil, efforts have been made to expand antenatal 
counseling, to offer HIV testing to all pregnant women and to improve 
subsequent management of HIV-positive patients4,5,14,22. Several authors 
have discussed the advantages and cost-effectiveness of rapid HIV 
testing and prophylaxis with zidovudine in preventing MTCT23. In the 
United States, it was demonstrated that this procedure would prevent 
vertical transmission and save US$ 3,000,000/year compared with no 
intervention21. In Mexico, a similar protocol was effective at reducing 
MTCT, increasing the coverage of pregnant women tested from 4% to 
85%, while saving US$ 42,517 per child infection29. 
A growing number of developed5 and developing countries have 
included rapid HIV screening in Public Health Programs. The protocol 
was included not only in maternity services, but also in places where 
antenatal care and laboratories facilities were not available26,27. Despite 
public health actions, some HIV-infected women are not aware of their 
HIV seropositive status prior to delivery. Therefore, they present a high 
risk of transmitting the virus to their newborns. The study objective was 
to use a rapid HIV test as a strategy to determine HIV prevalence and to 
prevent MTCT in pregnant women who had not been previously tested 
or were undocumented for HIV and were referred to the Gynecology 
and Obstetrics Service of a Regional Teaching Hospital.
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MATERIAL AND METHODS
Patients and Rapid HIV test: The “Dr. Leonardo Domingos 
Cerávolo” Teaching Hospital (TH) is a Regional General Hospital 
that serves a population of about 600,000 and is located in the city of 
Presidente Prudente, in one of the poorest regions of the State of São 
Paulo, Brazil. The study was conducted from January 2001 to December 
2005 on 16,424 pregnant referred to the Gynecology and Obstetrics 
Service of the TH. This was a retrospective study and was approved by 
the Institutional Ethics Committee (CEP), under protocol No 106/2004. 
The anonymity of the patients was maintained. 
Pregnant women, in the intrapartum period, and those submitted 
to obstetric-gynecological procedures, mainly abortion, but also 
including moderate and severe preeclampsia, urinary tract infection, 
gestational diabetes and anemia treatment, were all screened. Of the 
16,424 individuals referred to the service, a rapid HIV test was used on 
1,089 (6.6%). The inclusion criteria were that they had not been tested 
during antenatal care or were undocumented for HIV (required in the 
admission box). 
Determination of HIV-1/2 (Abbott Laboratories, Tokyo, Japan) was 
performed by an immunochromatographic rapid test. The reaction was 
based on the sandwich immunoassay technique with HIV-1 and HIV-2 
recombinant antigens, as well as peptides of HIV-1 and HIV-2 envelope 
antigens. In this study, the strips were analyzed by two trained professionals. 
In order to implement a rapid HIV test in the TH in 2001, evaluation of 
Determine HIV-1/2 (Abbott Laboratories, Tokyo, Japan) was conduced 
in 200 parturients31. The test showed specificity and sensitivity of 100%, 
similar to the rates obtained by different authors with Determine11,13. 
Enzyme Linked Immunoabsorbent Assay (ELISA): All pregnant 
women whose serum tested positive by the rapid HIV test were 
systematically screened for HIV-1/2. Two commercial third-generation 
assays from different manufacturers were used, according to standard 
government procedures (ELISA, GENELAVIAR MIXT, Sanofi 
Diagnostics Pasteur S.A., Marnes la Coquete, France, and Murex™ HIV-
1.2.0, Murex Biotech Limited, Dartford Kent England, UK). When the 
serum sample that resulted in a positive rapid HIV test was negative by 
ELISA, it was considered a false positive for HIV screening20. 
Prophylaxis of HIV-infected mothers detected by rapid HIV test was 
performed by intravenous injection of 2 mg/kg, followed by continuous 
infusion of 1 mg/kg/h until umbilical cord clamping. The newborns 
received a six-week course of zidovudine (2 mg/kg orally four times 
per day)4. Mothers were counseled not to breastfeed their infants. 
Clinical or pharmacological support was offered, as recommended by 
the Governmental Protocol3,4,17. After leaving the TH, the mothers were 
referred to a specialized regional public maternity unit8. 
Indirect Immunofluorescence Assay (IIA) or Western blot (WB): 
The confirmatory tests used were indirect immunofluorescence assay 
(slides from Bio-Manguinhos, Fiocruz Institute, Rio de Janeiro, Brazil) or 
Western blot (Genelabs Diagnostics Pte. Ltd., Singapore). The reactions 
were performed according to the manufacturer’s recommendations on the 
serum samples of all women with positive results by ELISA. Whenever 
the sample was positive by ELISA and IIA or WB, the sample was 
considered positive for HIV. 
bDNA Assay: Quantification of HIV-RNA was performed twice in 
plasma from newborns of HIV-positive mothers by bDNA. It was assayed 
using the Chiron Quantiplex version 3bDNA assay (Bayer Corporation, 
Emervylle, California, USA), according to the manufacturer’s 
instructions. The quantitative detection limits ranged from 50 to 500,000 
copies/mL. The assays were determined at the end of the second month 
and immediately after the fourth month. This protocol is in accordance 
with the Brazilian STD/AIDS program4,17. 
Statistical analysis: Data are expressed as mean ± SEM and statistical 
analysis consisted of the Student t test. Statistical significance was set 
at alpha lower than 5%. 
RESULTS
Of the 16,424 women analyzed, 1,089 (6.6%) had not been previously 
tested or were undocumented for HIV status. Most of them, 15,335 
(94.4%) were tested in public health care centers or private clinics. About 
70% of women were attended within the Unified National Health System 
(SUS) and 30% used the private sector. Less than 0.1% of the pregnant 
women who were attended by the private sector did not have antenatal 
care and HIV test.
Rapid HIV test: Of the 1,089 non-HIV-tested or undocumented 
women, 11 (1.0%) tested positive and 1,078 (99.0%) tested negative 
for HIV. All the women that tested positive for the rapid HIV test were 
attended by the SUS. In the present study, all the eligible patients agreed 
to be tested. 
Confirmatory Tests: Among the 11 specimens with a positive result 
by rapid HIV testing, 10 (0.91%) were confirmed by two distinct ELISA 
tests. One serum sample was negative (classified as a false positive), 
with a positivity of 0.9% for HIV infection. The 10 specimens that 
tested positive by ELISA were confirmed by IIA or WB. Among the 
HIV-positive women, six (60%) had not been tested during antenatal 
care. Four (40%) reported that they had previously been tested but were 
undocumented for HIV and two were being treated with antiretroviral 
therapy. Six (60%) were admitted during the intra-partum period, two 
(20%) underwent vaginal delivery, one (10%) had an emergency cesarean 
and three (30%) had elective cesarean sections. Four women (40%) were 
admitted for other gynecological procedures. In relation to ethnicity, 
eight (80%) were of European descent and two (20%) were of African 
or African-European descent. One woman (10%) was ≤ 18 years-old, 
five (50%) 18-30 years-old and four (40%) were older than 31 years-old. 
The time of membrane rupture (hours) for the mothers was not different 
from the normal range at the TH. 
bDNA Assay: All the live-born infants from HIV-infected mothers 
showed a viral load lower than 50 copies/mL, according to tests performed 
at least twice after birth. 
DISCUSSION
Globally, a considerable number of women remain unaware of their 
HIV serological status during the labor period2,6,28. Brazil was one of 
the first developing countries to implement measures to prevent MTCT 
of HIV. These efforts promoted a decrease in vertical transmission rates 
from 20%-30% detected in studies prior to ARV prophylaxis to 2%-5% 
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in the last few years15,17,19. A nationwide program of rapid HIV testing 
was one of the main strategies introduced during labor or at delivery 
by the Brazilian STD/AIDS program, to reduce the risk of perinatal 
transmission3,4. 
A higher number (93.4%) of pregnant women previously tested 
for HIV during antenatal care was verified compared to that obtained 
nationwide (85%)20. One possible explanation is the higher number of 
Public Health Care Centers distributed throughout the counties of the 
region. In these units, following the National Program of Obstetrics and 
Neonatal Attention, doctors are oriented to screen pregnant women for 
HIV. Furthermore, pregnant women at high-risk of infection by HIV and 
not previously tested during antenatal care are preferentially directed to 
a specialized regional public maternity unit8. 
In our region, the service within the Teaching Hospital is important 
for providing services to the SUS. Significant differences are described 
nationwide between patients attended at private and public maternities. 
Similar to the results obtained here, several authors have reported that 
pregnant women who come from less privileged social conditions, such 
as low income and poor access to prenatal care, are usually not counseled 
and tested for HIV7,14,17,24. In these situations, rapid HIV testing is of 
special interest. 
On the other hand, in the city of Ribeirão Preto, 20.1% of the 
pregnant women attended by the Gynecology and Obstetrics Service 
of the Hospital das Clínicas, from February to June 2001 were not 
screened at antenatal care clinics11. MATIDA et al. (2005)19 verified that 
in the State of São Paulo, about 15% of parturients were tested by rapid 
HIV test during maternity. In the State of Sergipe, screening conduced 
in three maternities linked to the SUS revealed that only 32.5% of 
pregnant women were tested for HIV in antenatal clinics18. These results 
demonstrate the discrepancies and local characteristics of HIV infection 
around the country. 
Despite all the planning and policy making, many factors may be 
involved in not performing the test as recommended. In this study, several 
mothers were from small municipalities where the tests are not available; 
thus, serum samples need to be analyzed in regional laboratories using 
the ELISA test and the results are only available to the patient several 
weeks or months after the sampling process. 
Among the pregnant women submitted to a rapid HIV infection test, 
positivity was 0.9%. Several studies have demonstrated the application 
of rapid HIV tests and the prevalence rates of HIV infection in women 
during labor periods9,18,22. In the State of Sergipe, in the Northeastern 
region of Brazil, 9,215 rapid HIV tests were performed in women during 
the intrapartum period who were not previously tested for HIV, resulting in 
0.42% infection18. The present data are different from a nationwide survey 
(0.42%) conducted in 2004 using the rapid HIV test, diagnosed during 
labor and delivery. Similar to this work, the rapid test was applied only in 
pregnant women with no prior documented HIV results20. It is difficult to 
discuss the reasons why these values were higher than the nationwide data, 
since risk factors and the probable route of acquisition of the mother’s HIV 
infection were not determined for the patients in this study. 
According to the Brazilian STD/AIDS protocol, a child is considered 
HIV uninfected after at least two negative DNA/PCR or bDNA tests, one 
of these should be performed after the age of four months-old4,17. In this 
survey, all the children were considered uninfected.
In middle-income regions, such as Brazil and Latin America, it is 
essential to measure the impact of rapid HIV test screenings as a part of 
the public effort to prevent MTCT. In the present study, the introduction 
of a rapid HIV test was efficient to determine the early diagnosis of 
HIV infection among pregnant women who had not been tested or 
were undocumented for HIV. Furthermore, this procedure provided an 
opportunity to administer both antiretroviral prophylaxis and incorporate 
other obstetric interventions to decrease vertical HIV transmission. 
RESUMO
Diagnóstico da infecção pelo HIV através de um teste rápido 
em gestantes sem resultados comprobatórios atendidas em um 
hospital escola do interior
No Brasil um número significativo de mulheres em idade gestacional 
ainda não foi testado para HIV, representando risco acentuado de 
transmissão vertical. Nosso objetivo foi determinar o número de gestantes 
que não foram previamente testadas ou não portavam documentos 
comprobatórios para HIV, ou seja, o diagnóstico da infecção para 
HIV através de um teste rápido e a transmissão vertical em gestantes 
admitidas no Departamento de Ginecologia e Obstetrícia de um Hospital 
Universitário Regional. Foram revisados os prontuários das gestantes 
admitidas entre janeiro de 2001 e dezembro de 2005. Gestantes sem 
resultados para HIV foram submetidas a um teste rápido. Testes 
positivos foram submetidos ao teste de ELISA e confirmados por 
imunofluorescência indireta (IIA) ou Western blot (WB). A carga viral 
dos recém-nascidos de mães infectadas foi determinada por bDNA. 
Dentre as 16.424 gestantes analisadas, 6,6% (1.089) não apresentaram 
resultados comprobatórios. Onze gestantes tiveram resultados positivos 
no teste rápido e 10 foram confirmadas por ELISA, IIA ou WB com 
0,9% de positividade. Mães e recém-nascidos receberam profilaxia com 
zidovudina e todos os recém-nascidos tiveram carga viral inferior a 50 
copias/mL. Foi encontrado um número maior de gestantes previamente 
testadas para HIV quando comparado à média obtida no país. 
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